US Anticoagulation Therapy Market Report 2017-2030 By Industry Share, Size, by Product Type and by Clinic Type

US Anticoagulation Therapy Market Overview

Thrombotic diseases caused by cancer progression have been reported as one of the major causes of cancer associated morbidity and mortality along with cancer invasiveness and infectious complications in US. Moreover, anticoagulant therapy with heparin and heparin-like drugs, or vitamin K antagonists, or the Direct Oral Anticoagulants, is seeing an extended application in cancer patients and offers prolonged life expectancy to oncology patients for whom blood activation and thrombotic events have a variable incidence, depending on cancer type.  The Anticoagulation Therapy market is expected to grow at a CAGR of 7.87% through 2030. Novel oral anticoagulant (NOACs) is the top performing segment as an alternative to anticoagulant. Increasing number of patients with lifelong medical aid therapy, growing prevalence of blood vessel thromboembolism, arrhythmia, and stroke, acceptance of NOAC’s is raising revenue in the market, rising outpatient anticoagulation therapy, increasing number of pipeline products under clinical trials and rising heparin trade spurring the growth of anticoagulation therapy market. However, high cost of developing drugs and risk of malfunctions like increased bleeding is main issue with newer agents are expected to impact the target market negatively.

US Anticoagulation Therapy Market Segmentation

By Product Type

Drugs

• Novel Oral Anticoagulants (NOACs)
• Warfarin (VKA)
• Other Drugs

PT/INR Testing Devices

• In-Office Testing Devices
• Analyzers
• Aeagents and Kits
• Home Testing Devices

Service

• Testing Services
• Consulting Services

By Clinic

• Hospital Associated Clinic
• Independent Clinics
• Pharmacy-based Clinics

Revenue Share by Product Type

The NOACs segment led the anticoagulation therapy market for drugs in 2017 owing to emergence of many pharma companies to develop more secure and structured NOAC’s in future years. The in-office testing devices dominated the market for PT/INR testing devices in 2017, while home testing devices is the fastest growing segment at a CAGR of 7.88% among the PT/INR testing devices. On the basis of services, the testing services held the largest market share of the anticoagulation therapy market for clinics in 2017, on the account of cost effectiveness and instant result generation saving time.

Covered In this United States Anticoagulation Therapy Market Report

The report covers the present ground scenario and the future growth prospects of the facility management market for 2017-2030 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players worldwide. Anticoagulation Therapy market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players.

United States Anticoagulation Therapy Market Outlook 2017-2030, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the Anticoagulation Therapy market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “United States Anticoagulation Therapy Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.

Key Market Players

Our United States Anticoagulation Therapy Market Report comprises of the following companies as the key players.

•  C. H. Boehringer Sohn
•  Bristol-Myers Squibb
•  Johnson & Johnson
•  Pfizer
•  Daiichi Sankyo 
•  Portola Pharmaceuticals
•  Roche
•  Abbott
•  Siemens
•  Alere
•  CoaguSense

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send here request for market report sample.

Key questions answered in this research report

• What is the total market size by 2030 and what would be the expected growth rate of market?
• What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for Anticoagulation Therapy Market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the Healthcare industry’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects
• Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
• Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Anticoagulation Therapy market
• Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
• To strategically profile key players and comprehensively analyze their market shares and core competencies